A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
CongXiao Zhang,*,1,2 XinWang Zhu,*,1 LuLu Li,1 TianKui Ma,1 Mai Shi,1 Ying Yang,1 QiuLing Fan11Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 2Blood Purification Center, Shenyang the 4th Hospital of People, Shenyang 11...
Main Authors: | Zhang C, Zhu X, Li L, Ma T, Shi M, Yang Y, Fan Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/a-small-molecule-inhibitor-mcc950-ameliorates-kidney-injury-in-diabeti-peer-reviewed-article-DMSO |
Similar Items
-
Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice
by: Yadong Zhai, et al.
Published: (2018-02-01) -
MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis
by: Lei Zhang, et al.
Published: (2021-11-01) -
The Small Molecule NLRP3 Inflammasome Inhibitor MCC950 Does Not Alter Wound Healing in Obese Mice
by: James S. Lee, et al.
Published: (2018-10-01) -
Dianthus superbus Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model
by: Jung Joo Yoon, et al.
Published: (2019-03-01) -
NLRP3 inflammasome and its inhibitors: a review
by: Bo-Zong eShao, et al.
Published: (2015-11-01)